The company aims to develop medical technologies and therapies. Furthermore, the company aims to develop its products in the field of cardiovascular medicine, with a focus on engineering and intellectual property as well as regulatory, clinical, management and financial processes. The company may establish branches in Switzerland and abroad, participate in other companies in Switzerland and abroad, acquire similar or related companies or merge with them, and enter into all transactions and contracts that are suitable to promote the purpose of the company or are directly or indirectly related to it. It may acquire, manage, encumber and dispose of real estate, copyrights, patents and licenses of all kinds. The company may grant loans or other financing to companies directly or indirectly connected with it, for consideration or free of charge, and provide security of all kinds, including by way of pledges or fiduciary transfers of its assets or by way of guarantees.